Akebia Therapeutics, Inc. · NASDAQ:AKBA
Akebia Therapeutics, Inc. shareholders
As of Jun 30, 2026, 165 institutions reported holding Akebia Therapeutics, Inc., 39.7% of its shares. Largest: BlackRock, Vanguard and AQR Capital Management LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Akebia Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 20M | 7.2% | +1.29M | Aug 7, 2026 |
| Vanguard | 16M | 5.8% | +744K | Aug 13, 2026 |
| AQR Capital Management LLC | 9.15M | 3.3% | +7.36M | Aug 14, 2026 |
| Geode Capital | 6.73M | 2.4% | +275K | Aug 12, 2026 |
| State Street | 5.39M | 1.9% | −6.22M | Aug 7, 2026 |
| Jacobs Levy Equity Management, Inc | 4.27M | 1.5% | +3.84M | Aug 14, 2026 |
| Acadian Asset Management LLC | 4M | 1.4% | +2.63M | Aug 13, 2026 |
| Nantahala Capital Management, LLC | 4M | 1.4% | +2M | Aug 19, 2026 |
| Goldman Sachs | 3.69M | 1.3% | +86,340 | Aug 14, 2026 |
| Millennium | 3.2M | 1.2% | +812K | Aug 14, 2026 |